PRÉPARATION CONTENANT UN ANTICORPS
The present invention relates to stable antibody-containing solution formulations in which aggregate formation of Emicizumab (ACE910) which is a bispecific antibody functionally substituting for FVIII, is suppressed. Specifically, the present invention relates to the above-mentioned antibody-contain...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | French |
Published |
06.03.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!